Breast cancer research in the era of precision medicine
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.0253-3766.2016.06.001
   		
        
        	
        		- VernacularTitle:精准医学时代的乳腺癌研究
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Haiyuan YANG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Yizhou JIANG
			        		
			        		;
		        		
		        		
		        		
			        		Zhiming SHAO
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 200032复旦大学附属肿瘤医院乳腺外科,复旦大学上海医学院肿瘤学系
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Precision medicine;
			        		
			        		
			        		
				        		Breast neoplasms;
			        		
			        		
			        		
				        		Omics
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Oncology
	            		
	            		 2016;38(6):401-403
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Precision medicine is an emerging medical strategy that takes into account individual molecular variations of disease to guide accurate prevention and treatment. Tumor molecular markers closely related to aggressive behavior and treatment response will be identified by integrating clinical information and multiple?omics, and will be verified in well?designed clinical trials. Breast cancer is a highly heterogeneous disease. Its treatment based on molecular subtyping has achieved initial success. However, drug resistance and tumor heterogeneity are still major challenges. This review will focus on the recent progress and future prospects of clinical research on breast cancer in the era of precision medicine.